This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Liver
CD2_BENIGN_LIVER_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum hepatis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Liver
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Liver
- Benign neoplasm: Liver/bile ducts
- Benign neoplasm: Liver/bile ducts
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 786 | 574 | 212 |
| Unadjusted period prevalence (%) | 0.17 | 0.20 | 0.09 |
| Median age at first event (years) | 52.28 | 48.71 | 61.94 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 677
- Matched controls
- 6769
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.4
ICD-10 Finland
Benign neoplasm: Liver
+∞
323.0
666
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
149.2
155.0
160
14
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
36.6
106.9
138
47
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
38.4
77.8
99
30
130
Kela drug reimbursment
Malignant tumour
+∞
58.2
55
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
30.4
56.6
76
28
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.8
53.3
147
266
H02AB02
ATC
dexamethasone; systemic
19.3
37.3
57
32
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
60.6
34.6
40
7
PJA12
NOMESCO Finland
Sentinel node biopsy
331.9
32.1
32
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
29.2
314
1695
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.6
28.7
108
270
115
Kela drug reimbursment
Breast cancer
+∞
28.3
27
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
9.8
28.3
58
64
C61
ICD-10 Finland
Malignant neoplasm of prostate
281.7
26.9
27
*
A04AA02
ATC
granisetron; systemic, transdermal
100.9
26.9
29
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
25.2
24
*
JN4BD
NOMESCO Finland
Extensive body CT
6.7
25.1
66
108
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
24.5
228
1108
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.9
23.0
165
683
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
22.8
123
416
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
15.3
21.4
35
24
UJF32
NOMESCO Finland
Coloscopy
2.6
21.1
193
914
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
20.9
20
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
20.9
20
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
113.5
20.7
22
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.5
20.4
42
47
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
20.0
132
513
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
56.7
19.0
22
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
18.8
18
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
18.8
18
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
102.9
18.7
20
*
D18.0
ICD-10 Finland
Haemangioma, any site
8.7
18.2
39
47
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
17.8
17
*
JN4CD
NOMESCO Finland
Very extensive body CT
11.9
17.7
32
28
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
16.9
209
1135
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
16.7
16
*
K76.89
ICD-10 Finland
Other specified diseases of liver
30.9
16.2
21
7
B01AB05
ATC
enoxaparin; parenteral
2.2
16.1
188
990
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
12.6
16.0
28
23
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
15.9
183
956
A02BC02
ATC
pantoprazole; systemic
2.0
15.9
435
3223
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
61.5
15.8
18
*
L01BC06
ATC
capecitabine; oral
+∞
15.7
15
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
15.7
15
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
15.7
15
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
15.7
15
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
15.7
15
*
L03AA13
ATC
pegfilgrastim; parenteral
163.6
15.5
16
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
20.6
15.2
22
11
A04AA01
ATC
ondansetron; systemic, rectal
6.1
14.4
39
67
XX3DW
NOMESCO Finland
Time consuming IT work
4.5
14.3
51
120
Z51.5
ICD-10 Finland
Palliative care
10.4
14.1
27
27
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.1
12.9
18
8
J01MA02
ATC
ciprofloxacin; systemic
1.9
12.8
255
1637
JJB71
NOMESCO Finland
Laparoscopic resection of liver
+∞
12.5
12
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
12.5
12
*
HAC20
NOMESCO Finland
Total mastectomy
132.4
12.5
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
12.3
248
1595
N02AX02
ATC
tramadol; systemic, rectal
1.8
12.2
267
1766
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
11.9
91
383
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
11.8
133
678
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.7
11.7
29
45
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
11.6
181
1055
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
11.5
11
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
11.5
11
*
21150
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Hepatis
+∞
11.5
11
*
ZX120
NOMESCO Finland
Intravenous
3.2
11.5
60
198
N02BE01
ATC
paracetamol; systemic, rectal
2.0
11.4
568
4871
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.3
11.3
57
183
WF002
NOMESCO Finland
Radical radiotherapy
35.7
11.3
14
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
35.7
11.3
14
*
WX402
NOMESCO Finland
General anaesthesia
2.3
11.2
109
516
K76.80
ICD-10 Finland
Hepatic cyst
13.0
11.2
19
15
JN4AD
NOMESCO Finland
Body CT examination
5.1
11.1
34
69
L02BG04
ATC
letrozole; oral
6.3
10.9
28
46
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
10.5
39
97
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
7.9
10.5
23
30
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
111.7
10.4
11
*
A04AD12
ATC
aprepitant; systemic
111.7
10.4
11
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
111.7
10.4
11
*
116
Kela drug reimbursment
Prostate cancer
+∞
10.4
10
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
10.4
10
*
X76
ICPC
Malignant neoplasm breast female
+∞
10.4
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.4
10
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
10.4
10
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
10.4
92
416
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
33.1
10.4
13
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
23.8
10.3
14
6
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
10.0
135
739
UKC02
NOMESCO Finland
Cystoscopy
2.4
9.8
89
408
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.0
9.8
38
99
XKD00
NOMESCO Finland
Uroflowmetry
2.5
9.6
80
351
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
30.5
9.4
12
*
L02BA01
ATC
tamoxifen; oral
30.5
9.4
12
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
9.4
9
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
9.4
9
*
L03AA02
ATC
filgrastim; parenteral
+∞
9.4
9
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
9.4
9
*
R4110
NOMESCO Finland
Physiotherapy
1.9
9.4
158
941
A02BC05
ATC
esomeprazole; systemic
1.7
9.3
262
1835
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
3.8
9.3
38
104
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.2
9.0
46
150
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
8.9
154
921
ZX080
NOMESCO Finland
Image guided radiotherapy
50.7
8.7
10
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
8.6
73
324
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.9
8.6
53
195
P01AB01
ATC
metronidazole; oral, rectal
1.6
8.5
272
1961
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
91.2
8.4
9
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.3
8
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
8.3
8
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
8.3
8
*
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
+∞
8.3
8
*
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
8.3
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
8.3
53
201
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
8.2
174
1110
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
8.1
47
167
B01AB10
ATC
tinzaparin; parenteral
3.3
8.1
40
128
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
8.0
119
672
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
22.3
8.0
11
5
HA1AA
NOMESCO Finland
X-ray mammography
3.7
8.0
33
92
Z3226
NOMESCO Finland
Physiotherapist
1.9
7.9
113
631
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
45.5
7.7
9
*
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
5.3
7.6
22
43
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
12.0
7.6
13
11
WX110
NOMESCO Finland
Local anesthesy
1.6
7.6
443
3678
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
7.6
142
869
NK6AN
NOMESCO Finland
Total body bone isotope imaging
25.3
7.6
10
*
N02AA05
ATC
oxycodone; systemic
2.4
7.5
61
265
A02BC01
ATC
omeprazole; systemic
1.7
7.5
174
1138
J01DB01
ATC
cefalexin; oral
1.7
7.4
534
4666
ZX090
NOMESCO Finland
Other technic of radiotherapy
80.9
7.4
8
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.1
7.4
86
443
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
4.3
7.4
26
63
J01MA12
ATC
levofloxacin; systemic
2.0
7.4
103
568
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
7.3
235
1680
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
7.3
7
*
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
+∞
7.3
7
*
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
15.9
7.2
11
7
JAH00
NOMESCO Finland
Laparotomy
4.5
7.2
24
55
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.3
7.1
33
102
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
6.9
100
560
A02BC03
ATC
lansoprazole; oral
1.6
6.9
188
1285
WX704
NOMESCO Finland
Intubation
2.7
6.9
44
168
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.2
6.8
17
28
R06.0
ICD-10 Finland
Dyspnoea
1.7
6.8
153
989
JJA20
NOMESCO Finland
Open biopsy of liver
40.5
6.8
8
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
6.8
205
1437
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
3.4
6.6
30
91
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
6.6
200
1402
Z3231
NOMESCO Finland
Registered nurse
1.7
6.5
162
1077
R51.80
ICD-10 Finland
Headache
1.8
6.5
107
627
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.3
6.5
57
258
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.5
6.5
28
82
Z51.0
ICD-10 Finland
Radiotherapy session
70.5
6.4
7
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
14.5
6.4
10
7
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
6.4
235
1724
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
6.3
6
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.3
6
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
7.1
6.2
14
20
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
26.9
6.2
8
*
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
26.9
6.2
8
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.4
6.2
50
218
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
6.1
36
131
WZC30
NOMESCO Finland
Teaching
2.2
6.1
64
313
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.3
6.1
52
233
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
5.0
6.1
18
37
ZXA00
NOMESCO Finland
Right side
1.7
6.1
144
944
N03AX16
ATC
pregabalin; oral
1.7
6.1
141
919
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
251
243
14.71
240.05
2.5
1.5
ug/l
2.6
2.8
0.31
170
184
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
146
52
34.25
222.38
1.8
1.8
u/ml
3.5
81.9
0.49
146
47
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
154
96
19.71
186.65
2.2
1.9
u/ml
11.0
133.7
0.80
136
75
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
584
2801
5.22
98.44
6.8
3.5
umol/l
10.4
10.8
0.45
561
2637
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
194
417
5.85
89.47
2.4
2.1
g/l
0.2
0.2
1.80
187
385
(40768441) Liver Pathology biopsy report
64
33
21.02
83.30
1.3
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
220
605
4.66
74.88
3.9
2.1
umol/l
5.2
5.6
0.44
194
514
(4035726)
104
164
7.16
64.69
1.4
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
462
2293
3.46
63.67
5.6
3.5
g/l
36.2
36.5
0.41
438
2135
(3032080) INR in Blood by Coagulation assay
424
2038
3.35
60.81
7.0
7.8
inr
1.2
1.2
0.55
91
609
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
684
4601
4.75
54.02
9.4
5.1
u/l
79.3
73.2
4.61
659
4280
(3033658) Prothrombin time (PT) actual/Normal
317
1363
3.22
53.35
5.7
3.1
%
96.8
93.8
1.22
309
1312
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
355
1868
2.64
38.17
3.2
2.2
u/l
56.7
56.1
0.08
327
1731
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
374
2061
2.55
35.97
4.2
2.5
u/l
30.5
29.0
0.57
361
1970
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
269
1283
2.67
34.69
2.4
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
322
1688
2.54
33.99
2.5
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
442
2716
2.43
32.43
4.0
3.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
73
158
4.99
32.17
1.3
1.2
titre
52.5
85.0
—
8
16
(3013826) Glucose [Moles/volume] in Serum or Plasma
508
3399
2.40
29.63
6.1
4.0
mmol/l
6.6
6.5
0.20
487
3108
(3034770) Mitochondria Ab [Titer] in Serum
70
166
4.53
27.57
1.3
1.2
—
968.0
—
0
5
(3013650) Neutrophils [#/volume] in Blood by Automated count
499
3375
2.31
27.45
8.7
6.5
e9/l
4.4
4.1
1.91
432
2959
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
385
2344
2.26
27.32
7.8
4.9
mmol/l
1.2
1.2
0.03
355
2101
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
414
2637
2.20
25.79
8.6
5.3
mmol/l
1.2
1.2
0.03
371
2255
(3020779) Urea [Moles/volume] in Serum or Plasma
111
389
3.16
24.72
8.0
6.8
mmol/l
7.7
9.4
1.44
105
369
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
158
684
2.64
23.77
3.1
2.2
%
23.9
24.0
0.04
145
582
(3004789) Transferrin [Mass/volume] in Serum or Plasma
168
767
2.51
22.55
2.9
2.1
g/l
2.5
2.4
1.09
157
712
(40768804) Tissue Pathology biopsy report
356
2221
2.10
22.45
2.6
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
129
528
2.73
21.56
1.3
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
176
848
2.39
20.85
3.0
2.1
umol/l
14.2
14.0
0.12
167
776
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
583
4448
2.20
20.64
4.4
2.8
u/l
60.2
39.5
7.63
561
4203
(3014576) Chloride [Moles/volume] in Serum or Plasma
133
571
2.60
20.14
9.7
6.7
mmol/l
105.1
104.4
1.31
133
561
(3019198) Lymphocytes [#/volume] in Blood
448
3147
1.99
19.29
6.1
5.4
e9/l
2.5
1.9
0.58
388
2811
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
120
504
2.63
18.94
3.1
2.1
u/l
31.4
35.6
0.49
98
422
(3013115) Eosinophils [#/volume] in Blood
449
3185
1.96
18.46
6.3
5.7
e9/l
0.2
0.2
1.50
383
2839
(3023368) Bacteria identified in Blood by Culture
223
1238
2.12
18.46
4.0
3.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
435
3057
1.95
18.35
6.1
5.4
e9/l
0.6
0.6
0.53
371
2688
(3006315) Basophils [#/volume] in Blood
436
3075
1.94
18.10
6.1
5.4
e9/l
0.0
0.0
0.02
372
2705
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
744
6474
3.79
17.85
16.8
10.3
mg/l
23.7
20.4
1.71
643
4925
(3031040) Bacteria [#/volume] in Urine by Automated count
534
4047
2.00
17.76
5.0
3.9
e6/l
439.7
2297.6
—
6
53
(42870588) Differential panel, method unspecified - Blood
304
1914
1.96
17.58
6.3
5.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
600
4749
2.11
17.56
4.3
3.9
mm/h
11.8
10.6
1.30
561
4410
(3003458) Phosphate [Moles/volume] in Serum or Plasma
138
651
2.36
16.89
6.1
4.7
mmol/l
1.0
1.0
0.09
126
594
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
105
437
2.62
16.81
4.3
3.2
u/l
226.2
235.4
0.41
100
413
(3002030) Lymphocytes/100 leukocytes in Blood
412
2938
1.85
15.67
6.3
5.6
%
28.8
29.0
0.13
389
2744
(3018095) Leukocytes [#/volume] in Urine
305
1986
1.88
15.46
4.4
3.3
e6/l
36.9
106.8
2.04
206
1320
(36304419) Bacteria [Presence] in Urine
240
1445
1.95
15.45
3.2
2.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
743
6560
3.42
15.32
18.5
11.7
mmol/l
139.6
139.7
0.19
734
6375
(3012095) Magnesium [Moles/volume] in Serum or Plasma
152
781
2.17
15.05
3.7
2.5
mmol/l
0.8
0.8
0.51
138
723
(3023103) Potassium [Moles/volume] in Serum or Plasma
743
6578
3.37
14.88
18.6
11.7
mmol/l
3.9
3.9
1.63
733
6378
(3018010) Neutrophils/100 leukocytes in Blood
406
2914
1.81
14.82
6.2
5.3
%
57.8
56.8
0.98
384
2731
(3019069) Monocytes/100 leukocytes in Blood
399
2849
1.81
14.81
6.6
5.8
%
7.9
8.2
1.28
377
2671
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
95
401
2.56
14.72
3.8
3.7
ng/l
77.7
81.9
0.24
79
365
(3006504) Eosinophils/100 leukocytes in Blood
397
2834
1.81
14.72
6.3
5.5
%
2.6
2.9
2.63
375
2639
(3007164) IgA [Mass/volume] in Serum or Plasma
221
1315
1.95
14.61
1.6
1.3
g/l
2.1
2.3
1.31
149
830
(3002582) Erythrocytes [#/volume] in Urine
257
1610
1.89
14.52
3.7
2.8
e6/l
54.8
101.7
0.44
186
1211
(3022145) Colonoscopy Study observation
127
615
2.27
14.51
1.4
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
238
1456
1.91
14.45
3.4
2.7
e6/l
0.3
0.4
0.39
164
1063
(3022096) Basophils/100 leukocytes in Blood
384
2733
1.79
14.21
6.3
5.6
%
0.6
0.7
0.77
361
2545
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
153
808
2.11
14.05
3.4
2.6
e6/l
3.1
3.1
0.03
80
412
(3015377) Calcium [Moles/volume] in Serum or Plasma
277
1795
1.84
13.95
3.0
2.0
mmol/l
2.4
2.3
1.41
242
1523
(3037467) Urinalysis macro (dipstick) panel - Urine
547
4351
1.85
13.67
4.6
3.9
—
—
—
0
0
(3036489) Thrombin time
60
209
3.03
13.37
2.8
1.8
s
23.0
21.0
0.43
52
184
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
113
539
2.28
13.33
9.3
7.5
kpa
5.2
5.1
0.44
113
518
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
64
235
2.88
12.98
8.0
11.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
158
868
2.03
12.96
2.7
2.4
e6/l
0.9
1.0
0.11
82
471
(3003396) Base excess in Arterial blood by calculation
111
533
2.26
12.87
9.1
7.5
mmol/l
0.4
1.4
1.91
94
407
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
228
1434
1.83
12.39
2.2
1.7
mg/l
1.1
0.9
0.35
179
1061
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
151
834
2.00
12.15
2.0
1.7
%
1.4
1.4
0.13
136
752
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
31
74
4.32
12.08
1.3
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
151
836
2.00
12.06
2.0
2.4
ug/g
124.8
104.1
0.37
116
655
(40758558) Short blood count panel - Blood
220
1380
1.83
12.01
7.5
4.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
241
1561
1.78
11.79
1.4
1.3
u/ml
0.6
2.0
2.78
72
457
(3018418) pH of Serum or Plasma
235
1526
1.77
11.32
5.3
3.0
ph
7.4
7.4
0.56
32
254
(40768797) Stomach Pathology biopsy report
152
864
1.94
11.19
1.3
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
16
8
20.38
11.16
1.4
2.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
139
770
1.98
11.02
1.5
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
161
942
1.89
10.84
1.5
1.3
titre
615.8
561.3
0.13
38
212
(3042936) Bacteria identified in Isolate by Culture
138
769
1.96
10.74
2.2
1.9
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
46
4.89
10.06
1.4
1.2
u/l
39.5
53.3
1.27
15
32
(3000991) Gas panel - Venous blood
78
362
2.28
9.76
12.5
8.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
226
1506
1.70
9.70
2.4
2.1
mg/l
2.7
2.8
0.27
193
1281
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
30
86
3.59
9.15
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
89
452
2.09
8.90
2.9
2.0
ml/min/173m2
80.6
72.5
0.92
37
177
(3000570) Elastase.pancreatic [Mass/mass] in Stool
42
151
2.88
8.88
1.5
1.4
ug/g
290.2
317.5
0.32
22
86
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
71
330
2.27
8.86
1.5
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
222
1503
1.66
8.85
3.0
2.2
umol/l
1456.1
5083.8
1.61
197
1309
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
297
2170
1.59
8.66
3.2
3.2
ng/l
26.5
56.5
0.86
176
1288
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
35
115
3.14
8.65
4.3
2.6
u/ml
0.3
0.4
1.69
16
57
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
6
20.28
8.49
5.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
20
45
4.53
8.40
1.5
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
152
945
1.75
8.23
2.9
1.9
mmol/l
2.5
2.4
3.22
137
814
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
166
1065
1.71
8.02
3.4
3.3
ng/l
1651.3
308.7
0.46
112
738
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
342
2616
1.54
7.98
2.9
2.3
nmol/l
73.1
76.4
1.47
312
2369
(3026782) Osmolality of Urine
162
1037
1.71
7.88
3.8
2.4
mosm/kgh2o
537.5
548.2
0.24
136
869
(3026008) Bacteria identified in Urine by Culture
243
1730
1.59
7.74
2.7
2.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
746
6944
2.46
7.51
13.5
8.1
u/l
28.6
25.3
4.72
731
6713
(3022217) INR in Platelet poor plasma by Coagulation assay
111
645
1.84
7.50
26.6
22.2
inr
1.3
1.3
—
10
89
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
673
6064
1.76
7.21
14.8
9.0
ml/min/173m2
86.9
85.2
1.22
567
4853
(3011397) Hemoglobin [Presence] in Urine by Test strip
203
1413
1.59
7.02
3.6
3.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
119
725
1.76
6.85
8.3
5.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
91
512
1.88
6.80
2.1
2.2
%
1.9
1.8
0.47
81
446
(3021601) Nitrite [Presence] in Urine by Test strip
388
3118
1.48
6.79
5.2
4.4
estimate
0.0
0.0
0.50
56
559
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
55
260
2.20
6.62
2.0
2.2
u/l
42.1
40.5
0.27
50
235
(3003327) Ova and parasites identified in Stool by Light microscopy
49
221
2.30
6.59
1.7
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
167
1125
1.62
6.58
2.9
2.3
e6/l
4.5
8.0
3.36
140
974
(3009261) Glucose [Presence] in Urine by Test strip
391
3166
1.47
6.48
3.9
3.2
estimate
0.0
0.0
0.50
53
542
(40768800) Prostate Pathology biopsy report
11
18
6.18
6.44
1.3
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
386
3122
1.46
6.41
4.0
3.2
estimate
0.0
0.0
0.00
53
558
(3001122) Ferritin [Mass/volume] in Serum or Plasma
385
3114
1.46
6.38
3.9
2.7
ug/l
112.4
93.4
1.06
365
2923
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
34
132
2.65
6.28
2.6
3.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
197
1393
1.55
6.28
1.7
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
92
535
1.82
6.19
1.4
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
27
94
2.94
6.10
2.5
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
504
4314
1.47
6.09
3.7
3.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
15
35
4.35
6.04
4.0
1.1
u/ml
11.1
54.1
—
5
9
(3023430) Cat dander IgE Ab [Units/volume] in Serum
27
95
2.91
5.99
1.0
1.1
u/ml
5.9
5.2
0.06
12
35
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
18
49
3.74
5.95
1.3
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
26
90
2.95
5.94
1.0
1.0
u/ml
0.1
0.1
—
8
21
(3003888) Timothy IgE Ab [Units/volume] in Serum
32
126
2.61
5.77
1.0
1.1
u/ml
1.7
5.4
1.34
17
64
(4010399)
79
448
1.85
5.76
1.6
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
308
2422
1.45
5.74
2.1
1.9
pmol/l
101.2
97.4
0.62
175
1279
(40761511) CBC panel - Blood by Automated count
737
6919
2.05
5.71
15.9
10.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
34
139
2.51
5.69
1.1
1.1
u/ml
0.8
2.4
0.80
12
53
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
21
5.30
5.53
1.1
1.3
ug/l
16.1
15.8
0.03
11
21
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
52
3.52
5.48
1.2
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
43
3.78
5.39
1.4
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
197
1435
1.50
5.38
2.8
2.8
ng/l
1348.8
969.2
0.49
167
1198
(3019060) Gas panel - Arterial blood
58
304
1.98
5.36
4.8
4.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
106
670
1.67
5.32
1.8
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
67
373
1.87
5.19
1.1
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
30
121
2.54
5.18
1.0
1.1
u/ml
0.3
0.9
1.96
11
53
(3005322) IgE [Units/volume] in Serum or Plasma
79
464
1.78
5.15
1.2
1.3
u/ml
116.6
224.2
1.18
72
429
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
90
551
1.72
5.08
1.7
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
51
262
2.01
5.00
1.6
1.7
—
—
—
0
0
(3020891) Body temperature
40
188
2.19
4.93
6.2
4.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
89
550
1.70
4.86
1.6
1.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
34
150
2.32
4.86
6.2
4.1
mmol/l
3.8
3.8
0.25
34
141
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
120
801
1.59
4.84
1.8
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
41
197
2.14
4.79
1.3
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
76
454
1.75
4.69
1.2
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
65
371
1.82
4.67
2.4
2.3
e9/l
67.7
71.6
0.54
51
276
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
5
14.11
4.58
2.9
1.0
u/ml
13.3
16.0
—
7
5
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
75
450
1.74
4.56
2.0
2.4
ug/l
7.7
6.6
0.17
66
395
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
53
288
1.90
4.44
2.7
2.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
28
118
2.42
4.44
1.0
1.1
u/ml
0.4
2.0
0.90
11
28
(4281824)
13
35
3.76
4.38
1.4
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
12
7.57
4.36
3.4
2.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
26
107
2.48
4.34
1.0
1.0
u/ml
1.5
2.9
0.64
13
36
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
57
320
1.84
4.33
1.4
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
326
2685
1.37
4.32
9.4
7.4
e9/l
0.0
0.0
0.78
258
2210
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
29
126
2.35
4.31
1.1
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
15
46
3.30
4.20
2.3
1.8
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
38
188
2.07
4.15
2.1
1.9
g/l
1.5
1.4
0.15
32
164
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
226
1764
1.39
4.13
2.1
2.1
u/l
152.5
195.9
0.43
213
1666
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
583
5281
1.40
4.12
4.8
4.1
pmol/l
14.6
14.5
0.14
538
4885
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
33
155
2.18
4.11
1.8
1.8
ug/l
5.3
1.5
0.43
26
140
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
12
32
3.79
4.09
2.7
3.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
32
3.79
4.09
1.2
1.0
—
—
—
0
0
(4306422)
24
98
2.49
4.08
1.4
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
37
183
2.07
4.05
5.9
3.7
mmol/l
1.1
1.4
1.20
37
178
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
49
268
1.88
4.05
1.6
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
54
305
1.83
4.04
3.5
2.1
nmol/l
12.3
12.9
0.19
45
271
(3019225) pH of Specimen
85
546
1.62
4.02
4.1
3.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
125
2.29
3.94
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
21
82
2.60
3.91
2.5
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
30
140
2.19
3.81
3.4
1.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
12
34
3.57
3.78
2.7
2.1
e9/l
1.5
1.2
—
6
17
(3017732) Neutrophils [#/volume] in Blood
71
444
1.66
3.74
2.1
2.5
e9/l
4.3
4.1
0.37
49
349
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
69
429
1.67
3.72
3.2
3.2
pmol/l
4.4
4.6
0.81
62
376
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
103
2.37
3.70
1.2
1.1
—
—
—
0
0
(3012544) pH of Venous blood
73
462
1.64
3.68
4.4
3.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
180
1376
1.40
3.67
1.6
1.5
nmol/l
19.2
21.3
1.24
152
1195
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
25
110
2.31
3.65
1.6
1.2
u/ml
2.0
9.0
1.27
12
39
(3019309) Folate [Moles/volume] in Red Blood Cells
138
1007
1.45
3.64
1.7
1.7
nmol/l
1127.8
1208.6
0.51
108
762
(3002385) Erythrocyte distribution width [Ratio]
600
5505
1.38
3.59
21.0
12.4
%
13.7
13.5
0.96
595
5382
(40761535) Cells panel - Urine sediment
72
458
1.63
3.56
3.7
2.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
155
1162
1.42
3.53
1.7
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
31
3.58
3.49
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
31
3.58
3.49
1.2
1.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
88
594
1.54
3.40
2.0
1.8
nmol/l
409.6
369.1
0.87
74
545
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
663
6205
1.44
3.38
5.8
4.7
mu/l
1.7
2.0
0.99
621
5770
(3003694) ABO and Rh group [Type] in Blood
218
1742
1.35
3.35
1.4
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
23
102
2.29
3.32
1.6
1.2
u/ml
1.4
3.8
—
8
33
(4268621)
18
72
2.54
3.23
2.9
2.2
—
—
—
0
0
(3013512) EKG study
201
1595
1.35
3.22
4.0
3.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
97
2.30
3.22
1.1
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
69
446
1.60
3.21
4.6
3.2
mmol/l
2.2
2.1
0.03
57
350
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
40
222
1.84
3.21
1.8
1.5
g/l
1.3
1.2
0.79
40
208
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
28
3.60
3.20
1.5
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
91
2.34
3.19
1.2
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
59
368
1.65
3.17
1.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
72
472
1.58
3.17
1.5
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
9
20
4.54
3.12
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
20
4.54
3.12
1.0
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
56
347
1.66
3.09
1.1
1.1
—
152.6
—
0
8
(3004588) Protein electrophoresis panel - Serum or Plasma
51
310
1.69
3.03
2.1
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
60
384
1.61
2.93
2.2
1.6
g/l
66.4
67.9
0.86
53
343
(3007461) Platelets [#/volume] in Blood
759
7357
1.92
2.90
26.1
15.5
e9/l
267.4
258.3
2.83
743
7184
(3048929) Epstein Barr virus Ab [Presence] in Serum
37
208
1.82
2.87
1.2
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
759
7359
1.91
2.87
26.1
15.4
fl
90.3
90.6
0.87
751
7259
(3009508) Creatinine [Moles/volume] in Urine
225
1843
1.31
2.86
3.6
3.0
mmol/l
7.7
7.6
0.02
199
1571
(3035941) MCH [Entitic mass]
759
7361
1.91
2.83
26.0
15.4
pg
30.0
30.2
2.88
751
7260
(3052851) Hemolysis interference index of Serum or Plasma
28
144
1.98
2.83
2.9
3.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
89
627
1.47
2.83
1.8
1.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
759
7362
1.90
2.81
26.1
15.5
e12/l
4.5
4.5
0.34
744
7170
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
18
4.48
2.80
1.5
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
759
7363
1.90
2.80
26.2
15.5
e9/l
7.1
6.6
6.48
744
7166
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
14
5.03
2.73
1.0
1.1
%
92.7
108.1
—
7
14
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
14
5.03
2.73
1.0
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
759
7367
1.88
2.73
26.3
15.6
g/l
134.5
135.8
2.15
752
7266
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
14
54
2.62
2.71
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
287
2444
1.27
2.68
4.3
3.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
24
120
2.03
2.63
1.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
177
1423
1.31
2.56
1.6
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
11
5.49
2.54
1.8
2.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
75
2.29
2.52
1.3
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
75
2.29
2.52
1.3
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
75
2.29
2.52
1.3
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
21
3.84
2.46
3.5
2.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
632
5951
1.32
2.43
6.5
5.2
mmol/mol
39.8
39.1
1.03
598
5587
(3009445) Proteinase 3 Ab [Units/volume] in Serum
41
251
1.67
2.41
1.3
1.7
—
9.1
—
0
7
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
37
221
1.71
2.38
6.0
3.2
mmol/l
24.6
24.4
0.17
32
194
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
159
1272
1.31
2.37
1.3
1.3
iu/ml
28.1
32.3
0.18
44
409
(3034426) Prothrombin time (PT)
8
22
3.66
2.37
1.8
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
173
1401
1.30
2.36
4.8
3.4
kg/l
1.0
1.0
0.61
21
197
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
78
2.21
2.32
1.3
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
78
2.21
2.32
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
78
2.21
2.32
1.3
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
72
2.25
2.29
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
106
2.01
2.27
1.5
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
18
3.91
2.25
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
39
241
1.65
2.23
2.8
3.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
21
107
1.99
2.22
3.0
6.2
mmol/l
103.0
104.9
0.80
21
98
(3039000) Anion gap in Blood
21
107
1.99
2.22
3.0
6.2
mmol/l
11.6
11.1
0.24
21
98
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
9
5.58
2.21
1.6
1.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
28
158
1.80
2.20
3.4
5.7
mmol/l
1.2
1.2
0.17
28
143
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
173
1.76
2.20
2.7
1.4
g/l
2.8
3.0
1.36
23
133
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
48
2.52
2.19
1.6
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
11
42
2.64
2.19
1.1
1.0
u/ml
1.6
0.3
—
5
15
(40768793) Breast Pathology biopsy report
15
67
2.26
2.18
1.4
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
165
0.36
2.17
1.7
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
105
803
1.36
2.13
1.3
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
52
349
1.52
2.13
1.7
2.1
u/l
5712.2
3517.1
0.25
15
150
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
39
245
1.62
2.11
1.9
1.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
34
206
1.68
2.11
2.6
4.4
%
0.9
0.9
0.29
34
195
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
69
493
1.44
2.08
1.7
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
211
1778
1.26
2.08
4.5
3.9
mg/mmol
16.3
8.7
0.71
150
1111
(3042733) HLA Ab [Presence] in Serum
5
10
5.02
2.07
2.0
3.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
34
208
1.66
2.04
2.7
4.3
%
1.7
1.6
0.18
34
197
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
15
4.02
2.04
1.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
94
712
1.36
2.03
1.5
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
50
2.42
2.03
1.7
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
150
1216
1.29
2.03
1.3
1.3
u/ml
19.3
12.0
0.41
66
479
(3012516) Albumin [Mass/volume] in Urine
201
1689
1.26
2.03
3.8
3.2
mg/l
588.4
297.8
0.35
141
1054
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
111
1.92
2.02
1.4
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
26
3.10
2.01
1.1
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
64
455
1.44
1.99
1.4
1.3
iu/l
24.7
28.1
0.38
54
395
(3029937) Albumin [Presence] in Urine by Test strip
194
1628
1.25
1.98
4.8
3.4
estimate
0.0
0.0
0.88
54
555
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
105
1.93
1.97
1.7
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
16
3.77
1.93
1.3
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
16
3.77
1.93
3.0
2.0
ug/l
59.2
45.6
—
6
16
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
16
3.77
1.93
1.3
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
16
3.77
1.93
1.3
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
659
6292
1.29
1.91
4.3
3.7
mmol/l
1.4
1.3
5.24
614
5843
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
65
2.17
1.89
1.4
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
52
2.33
1.88
1.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
684
6569
1.32
1.85
4.8
4.1
mmol/l
4.7
4.8
0.46
647
6172
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
183
1.66
1.84
2.7
1.3
g/l
6.7
7.4
1.79
23
139
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
183
1.66
1.84
2.7
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
183
1.66
1.84
2.7
1.3
g/l
3.7
3.8
0.17
23
131
(40761536) Microorganisms panel - Urine sediment
32
498
0.63
1.84
4.5
3.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
14
66
2.14
1.82
1.8
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
23
3.06
1.80
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
201
1715
1.23
1.75
1.7
1.7
mmol/l
1.6
1.4
2.57
184
1477
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
97
757
1.32
1.74
4.4
4.3
%
31.3
32.0
0.23
64
526
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
54
2.24
1.74
1.1
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
210
1.60
1.73
1.5
1.6
iu/ml
0.1
0.1
—
10
34
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
680
6539
1.30
1.72
4.7
4.1
mmol/l
1.5
1.5
1.73
637
6121
(40768795) Lymph node Pathology biopsy report
5
13
3.86
1.71
1.2
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
55
2.20
1.68
1.1
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
83
1.95
1.65
1.9
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
506
4726
1.20
1.65
3.7
3.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
60
438
1.40
1.65
1.3
1.3
—
42.5
—
0
22
(40768806) Pleura Pathology biopsy report
7
25
2.82
1.65
2.4
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
644
6161
1.25
1.64
20.1
11.4
%
39.8
40.1
0.34
500
4694
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
166
1.65
1.63
2.9
1.3
g/l
9.9
10.5
0.37
22
142
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
14
3.59
1.61
1.2
2.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
43
2.34
1.60
1.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
43
2.34
1.60
1.3
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
43
2.34
1.60
1.3
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
92
722
1.31
1.60
3.1
2.5
ug/l
0.9
0.7
0.65
64
468
(3051651) Icteric interference index of Serum or Plasma
6
20
3.01
1.58
2.7
1.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
129
1.73
1.58
1.4
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
45
316
1.45
1.54
3.1
3.1
mmol/l
1.3
1.7
0.31
36
237
(3045142) Bone marrow Pathology biopsy report
8
33
2.44
1.54
1.9
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
33
2.44
1.54
1.5
2.3
u/ml
4819.0
666.0
—
8
33
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
47
334
1.43
1.51
3.1
3.1
kpa
5.2
5.1
0.07
40
314
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
86
1.88
1.51
1.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
21
2.87
1.51
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
30
194
1.57
1.50
1.5
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
18
101
1.80
1.50
2.2
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
173
1478
1.22
1.48
2.9
4.0
—
—
—
0
0
(3000492) Spirometry study
81
633
1.31
1.47
1.5
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
34
228
1.51
1.46
2.9
3.4
%
41.4
47.6
0.87
34
223
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
80
1.89
1.45
1.1
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
123
1016
1.25
1.44
4.3
3.6
%
21.3
24.1
1.62
71
464
(44790049)
12
59
2.05
1.44
1.6
1.4
—
—
—
0
0
(44790047)
12
59
2.05
1.44
1.6
1.4
—
—
—
0
0
(44790048)
12
59
2.05
1.44
1.6
1.4
—
—
—
0
0
(44806118)
12
59
2.05
1.44
1.6
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
17
95
1.81
1.44
1.6
1.3
u/ml
93.5
119.3
—
5
21
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
22
2.74
1.43
1.7
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
22
2.74
1.43
1.7
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
39
2.32
1.43
1.6
4.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
149
1262
1.22
1.39
5.5
3.7
ug/l
2.8
2.0
1.54
138
1130
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
53
2.09
1.39
2.7
4.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
28
183
1.55
1.36
4.2
2.4
g/l
0.2
0.3
0.26
13
60
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
42
2.16
1.34
1.9
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
90
1.79
1.34
1.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
90
1.79
1.34
1.1
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
90
1.79
1.34
1.3
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
61
1.98
1.33
1.6
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
24
2.51
1.30
1.7
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
43
2.11
1.30
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
43
2.11
1.30
1.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
32
218
1.49
1.30
1.3
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
31
210
1.50
1.29
1.2
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
8
34
2.37
1.29
1.5
1.6
—
1.4
—
0
7
(4062490)
13
69
1.90
1.29
1.5
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
659
6361
1.22
1.29
4.8
4.1
mmol/l
5.9
5.8
0.97
617
5891
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
29
194
1.51
1.28
1.4
1.2
u/ml
1.6
2.8
—
5
24
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
44
2.06
1.27
1.1
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
35
2.30
1.27
1.0
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
18
107
1.70
1.26
1.3
1.2
u/ml
176.5
223.5
—
8
65
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
687
6663
1.25
1.26
5.3
4.5
mmol/l
2.8
2.8
1.54
646
6242
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
45
330
1.39
1.25
1.5
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
6
25
2.41
1.24
1.0
1.1
g/l
0.3
0.3
—
6
19
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
49
2.05
1.22
1.6
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
19
2.64
1.21
1.6
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
8
38
2.12
1.18
2.5
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29
198
1.48
1.18
1.4
1.2
u/ml
5.1
10.6
—
8
37
(3009214) Lutropin [Units/volume] in Serum or Plasma
27
182
1.50
1.17
1.2
1.2
u/l
11.6
10.8
0.10
18
150
(3043410) Blood group antigens tested for on Red Blood Cells
5
20
2.51
1.15
1.4
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
20
2.51
1.15
1.6
1.6
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
5
20
2.51
1.15
1.2
2.1
e9/l
0.2
0.2
—
5
20
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
51
388
1.34
1.15
4.5
2.2
mmol/l
1.2
1.2
0.42
46
326
(3027273) Bicarbonate [Moles/volume] in Venous blood
34
242
1.42
1.13
2.9
3.1
mmol/l
25.3
25.5
0.10
34
233
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
58
1.91
1.12
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
58
1.91
1.12
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
58
1.91
1.12
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
20
127
1.59
1.12
1.4
1.3
u/l
23.9
25.9
0.09
15
100
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
15
88
1.72
1.12
1.1
1.2
nmol/l
0.5
0.6
0.53
15
83
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
51
1.97
1.11
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
19
120
1.60
1.09
1.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
231
2555
0.86
1.09
2.4
2.6
—
—
—
0
0
(1002224) Polysomnography panel
45
339
1.35
1.09
1.0
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
15
89
1.70
1.08
1.1
1.2
nmol/l
—
0.7
—
0
7
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
59
1.88
1.07
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
59
1.88
1.07
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
59
1.88
1.07
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
33
2.13
1.05
2.1
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
22
2.28
1.03
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
22
2.28
1.03
1.2
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
22
2.28
1.03
1.8
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
27
188
1.45
1.02
1.9
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
32
231
1.40
1.01
1.3
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
18
115
1.58
1.00
1.1
1.4
nmol/l
0.3
0.4
0.88
13
98
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
33
240
1.39
1.00
1.4
2.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
61
1.81
0.98
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
54
1.86
0.97
1.2
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
62
1.79
0.94
1.5
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
101
1.60
0.94
1.6
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
196
0.61
0.93
2.3
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
118
1023
1.18
0.89
2.2
2.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
71
1.70
0.89
2.8
2.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
186
1.41
0.88
1.3
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
64
1.73
0.86
1.0
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
44
1.83
0.86
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
37
478
0.76
0.85
1.4
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
137
1.47
0.84
2.8
2.2
ug/min
78.0
128.2
0.38
13
89
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
214
1.37
0.83
1.8
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
81
1.62
0.81
1.8
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
141
1255
1.15
0.78
1.6
1.7
pmol/l
414.0
35768215.0
1.77
122
1068
(42529406) Shigella sp [Presence] in Stool by Culture
26
191
1.37
0.78
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
38
297
1.29
0.76
1.4
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
59
1.70
0.76
1.4
1.1
—
—
—
0
0
(44813793)
9
53
1.71
0.75
1.1
1.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
9
53
1.71
0.75
1.1
1.5
nmol/l
1.5
1.4
—
9
46
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
9
54
1.67
0.74
1.0
1.0
mg/l
180.2
219.8
—
9
43
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
26
193
1.36
0.74
1.7
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
100
1.51
0.73
1.7
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
105
919
1.16
0.73
2.0
1.9
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
25
2.01
0.72
1.6
2.3
%
182.1
112.8
—
5
25
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
185
1.36
0.72
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
39
1.80
0.72
3.4
2.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
21
151
1.40
0.72
1.1
1.2
mmol/l
4.0
3.8
0.36
21
139
(3021440) Promyelocytes/100 leukocytes in Blood
50
409
1.24
0.71
3.5
4.5
%
0.1
0.0
0.24
11
82
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
9
57
1.59
0.71
1.2
1.1
mg/l
33.4
31.4
—
9
43
(3000764) Benzodiazepines [Presence] in Urine
36
283
1.29
0.71
1.4
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
5
26
1.93
0.70
1.0
1.1
%
100.8
116.4
—
5
20
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
26
1.93
0.70
1.0
2.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
41
1.71
0.70
1.6
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
36
284
1.28
0.69
1.4
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
42
1.67
0.68
1.1
1.2
—
19.8
—
0
6
(3028300) Cannabinoids [Presence] in Urine
36
286
1.27
0.66
1.4
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
157
1425
1.13
0.66
1.9
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
21
281
0.74
0.65
1.5
1.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
48
396
1.23
0.65
3.2
4.3
%
0.0
0.3
—
8
69
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
29
1.73
0.64
1.0
1.4
u/l
183.8
185.3
—
5
29
(3045788) Cell count panel - Pleural fluid
5
29
1.73
0.64
2.8
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
131
0.61
0.64
1.1
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
87
1.50
0.63
2.1
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
192
1768
1.11
0.63
3.6
2.9
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
10
63
1.59
0.62
5.1
1.8
—
—
—
0
0
(3016750) Collection duration of Urine
5
30
1.67
0.61
2.6
2.1
min
510.2
494.8
—
5
19
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
22
165
1.34
0.61
1.1
1.3
mg/l
467.8
419.6
0.22
22
153
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
42
508
0.82
0.60
3.2
2.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
148
1.36
0.60
1.5
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
35
282
1.25
0.59
1.4
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
53
1.51
0.58
1.0
1.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
6
35
1.72
0.57
1.0
1.8
—
47.0
—
0
5
(3039443) Prostate specific Ag panel - Serum or Plasma
12
81
1.49
0.57
1.6
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
65
1.55
0.55
1.1
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
37
1.63
0.55
1.3
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
6
37
1.63
0.55
1.7
1.1
—
1.0
—
0
13
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
63
544
1.17
0.55
1.2
1.2
iu/ml
151.2
148.3
0.02
23
228
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
186
1.30
0.55
1.2
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
125
1.37
0.54
1.5
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
178
1.30
0.53
1.1
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
33
268
1.24
0.53
1.4
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
50
425
1.19
0.52
3.5
4.3
%
1.1
0.7
0.13
11
90
(3004775) Volume in Urine collected for unspecified duration
6
40
1.50
0.51
3.0
2.1
ml
645.5
563.3
—
6
23
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
17
225
0.75
0.51
1.5
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
41
1.47
0.50
2.7
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.6
1.6
—
—
—
0
0
(4027681)
7
48
1.46
0.47
1.0
1.2
—
—
—
0
0
(4034850)
18
232
0.77
0.46
3.6
8.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
265
0.79
0.46
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
265
0.79
0.46
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
264
0.79
0.45
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
264
0.79
0.45
1.3
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
69
1.46
0.44
1.3
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
7
51
1.38
0.44
1.4
1.1
—
2.2
—
0
5
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
78
1.42
0.43
1.1
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
56
1.43
0.42
2.8
2.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
32
1.57
0.42
2.0
1.5
nmol/l
140.6
146.4
—
5
32
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
96
1.36
0.41
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
74
823
0.89
0.41
1.4
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
17
0.00
0.40
0.0
1.2
—
36.5
—
0
11
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
127
1.27
0.33
1.6
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
44
496
0.88
0.32
1.4
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
37
323
1.15
0.32
1.4
1.7
mg/l
4.0
3.2
0.27
28
215
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
219
0.82
0.31
1.3
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
96
0.73
0.31
4.3
2.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
17
138
1.24
0.30
1.6
1.5
e6/l
6111.9
12882.0
—
10
96
(3005033) Fetal Nuchal fold Thickness US
18
218
0.82
0.30
1.3
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
24
282
0.85
0.30
4.1
3.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
111
1.27
0.30
1.2
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
93
1.29
0.30
1.2
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
106
0.75
0.29
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
106
0.75
0.29
1.9
3.9
%
59.0
56.1
—
8
106
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
57
1.23
0.29
1.4
1.1
—
94.4
—
0
5
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
227
0.83
0.28
1.4
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
25
288
0.86
0.26
1.4
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
75
1.20
0.25
1.0
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
96
1.25
0.24
1.3
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
44
398
1.11
0.24
3.3
4.5
%
0.0
1.3
—
9
73
(3021901) Oxygen saturation in Capillary blood
6
82
0.73
0.24
4.2
2.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
115
1.22
0.23
1.3
1.1
—
14.1
—
0
10
(3008898) HLA-B27 [Presence]
34
304
1.12
0.23
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
40
1.25
0.22
1.8
2.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
41
1.22
0.22
1.4
2.0
%
11.0
10.4
—
5
41
(3045414) Leukocytes [Presence] in Urine
30
267
1.13
0.22
1.8
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
35
315
1.12
0.21
1.3
1.6
mu/l
251.5
325.4
1.39
30
283
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
11
0.00
0.21
0.0
2.1
—
0.6
—
0
11
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
10
0.00
0.21
0.0
6.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
12
0.00
0.21
0.0
5.8
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
12
0.00
0.21
0.0
5.9
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
105
0.76
0.21
1.9
3.6
e9/l
4.7
4.1
—
8
105
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
43
1.16
0.21
1.4
1.4
mmol/l
5.1
5.7
—
5
43
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
89
1.24
0.21
1.1
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
29
324
0.89
0.20
1.6
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
6
48
1.25
0.20
1.0
1.3
promille
1.2
1.6
—
6
37
(3003129) Base excess in Capillary blood by calculation
0
14
0.00
0.20
0.0
1.3
—
1.9
—
0
14
(3024928) Oxygen saturation in Venous blood
13
108
1.21
0.20
4.2
2.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
51
1.18
0.19
1.8
2.0
pg
32.2
32.3
—
6
51
(3019832) Treponema pallidum Ab [Presence] in Serum
82
867
0.94
0.19
1.6
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
137
1.17
0.19
1.0
1.5
—
—
—
0
0
(4146454)
7
59
1.19
0.18
4.3
2.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
67
0.74
0.17
1.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
69
0.72
0.17
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
92
1.20
0.16
1.3
1.4
—
—
—
0
0
(4094501)
14
159
0.88
0.13
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
104
1.16
0.12
1.1
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
114
1.14
0.12
1.3
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
37
394
0.94
0.11
2.2
2.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
30
279
1.08
0.11
1.1
1.3
miu/ml
221.1
246.3
0.22
16
141
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
44
1.14
0.10
1.2
1.3
—
—
—
0
0
(4024509)
5
45
1.11
0.10
2.0
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
45
1.11
0.10
1.0
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
67
696
0.96
0.09
1.5
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
155
1.10
0.09
1.2
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
6
54
1.11
0.09
1.3
1.4
—
63.6
—
0
7
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
134
0.89
0.08
1.8
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
57
1.05
0.08
1.0
1.9
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
196
1.07
0.07
1.5
1.9
iu/l
1.8
5.0
—
5
82
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
121
0.91
0.06
1.6
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
89
872
1.02
0.05
1.9
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
41
396
1.04
0.05
1.5
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
150
0.93
0.04
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
13
123
1.06
0.01
1.5
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
13
126
1.03
0.00
1.0
1.0
u/ml
1.6
2.5
—
6
62
(3001019) Free T4 and TSH panel - Serum or Plasma
49
495
0.99
0.00
1.9
1.8
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
10
102
0.98
0.00
1.2
1.1
—
71.4
—
0
24
(1761482) Bacteria [#/volume] in Urine by Culture
14
142
0.99
0.00
5.9
4.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
131
0.99
0.00
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
131
0.99
0.00
1.1
1.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
8.0
—
0
6
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
6.6
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
163.3
—
0
6
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
79
0.89
0.00
1.1
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
96.6
—
0
9
(3035285) Chloride [Moles/volume] in Venous blood
6
67
0.89
0.00
3.3
2.5
mmol/l
107.8
106.0
—
6
67
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
71
0.99
0.00
2.0
2.7
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
41.4
—
0
5
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
65
0.92
0.00
3.3
2.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
67
0.89
0.00
3.3
2.5
mmol/l
4.6
4.1
—
6
67
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_LIVER_EXALLC – Benign neoplasm: Liver
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).